# DHEA in women: what the studies included · PepVault guides

Source: https://pepvault.app/guides/dhea-for-women

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [Hormones and blood tests](https://pepvault.app/guides#hormones)

# DHEA in women: what the studies included

Reviewed November 2026 20 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Who the DHEA trials enrolled: older women, adrenal insufficiency, IVF poor responders and menopause. Each trial's women, ages, dose and result in one table.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 20
- **Questions:** 7
- **Compounds:** 1

## The short answer

DHEA has been tested in four groups of women: women over 60 with low levels, women whose adrenal glands have failed, women aged 18 to 42 who respond poorly to IVF, and women aged 40 to 80 with painful sex after menopause. Oral DHEA, usually 50 mg a day, raised testosterone and acne more reliably than wellbeing or libido. The clearest result is the FDA-approved vaginal insert, Intrarosa.

Every number checked at its primary source · Nov 20, 2026 · [20 sources](https://pepvault.app/guides/dhea-for-women#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Randomized trials in women, most small (24 to 93 women) and short, two FDA-reviewed trials of the vaginal insert (255 and 558 women), and meta-analyses of moderate to low certainty.

## Which women were in the DHEA studies?

DHEA (dehydroepiandrosterone) is an adrenal hormone that the body turns into testosterone and estrogens. It is sold to men as a testosterone booster, yet women have carried much of its research. In the largest long trial, at the Mayo Clinic, 57 of the 144 older adults were women[1](https://pepvault.app/guides/dhea-for-women#source-1). In the year-long French DHEAge study, 140 of 280 were[4](https://pepvault.app/guides/dhea-for-women#source-4). The pooled reviews count women only: 1,273 menopausal women in one, about 3,000 women going through IVF in another[15](https://pepvault.app/guides/dhea-for-women#source-15) [19](https://pepvault.app/guides/dhea-for-women#source-19).

The women fall into four groups, and the answer changes with the group. Older women were given DHEA to replace a level that falls with age. Women with adrenal insufficiency, whose adrenal glands make almost none, were given it to replace what is missing. Women who respond poorly to IVF stimulation were given it to get more from their ovaries. And postmenopausal women with pain at sex got it as a vaginal insert[12](https://pepvault.app/guides/dhea-for-women#source-12).

<!--promo-->

DHEA is in PepVault's library. Add it to a protocol as an oral supplement, and the app logs each day's capsule so you and your prescriber can see exactly when you started. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-dhea-for-women-inline&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

DHEA is in PepVault's library. Add it to a protocol as an oral supplement, and the app logs each day's capsule so you and your prescriber can see exactly when you started.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Who did each DHEA trial enroll, and what did it find?

Here is each trial, one row each: who, how many women, their ages, the dose as the trial gave it, what it measured and what it found. A crossover trial gives each woman both DHEA and placebo, one after the other (pepvault.app/glossary/crossover-trial).

| Who | Women | Ages | Trial dose | Measured | Found |
| --- | --- | --- | --- | --- | --- |
| Older women with low DHEA-S (Mayo Clinic, 2 years) | 57 (27 DHEA, 30 placebo) | 60 and over | 50 mg a day by mouth | Strength, fitness, body fat, insulin sensitivity, bone, quality of life | No change, except bone density up at the wrist; HDL cholesterol down 5 mg/dL[1](https://pepvault.app/guides/dhea-for-women#source-1) [2](https://pepvault.app/guides/dhea-for-women#source-2) [3](https://pepvault.app/guides/dhea-for-women#source-3) |
| Healthy older adults (DHEAge, 1 year) | 140 of 280 | 60 to 79 | 50 mg a day by mouth | Hormones, bone, libido, skin | Bone turnover and most libido measures improved in women over 70; skin hydration and thickness improved[4](https://pepvault.app/guides/dhea-for-women#source-4) |
| Postmenopausal women with low libido, not on estrogen | 93 | Postmenopausal | 50 mg a day by mouth, 52 weeks | Satisfying sexual events, wellbeing, menopause quality of life | No difference from placebo at 26 weeks; more acne and hair growth; lipids, insulin and the womb lining unchanged[5](https://pepvault.app/guides/dhea-for-women#source-5) [6](https://pepvault.app/guides/dhea-for-women#source-6) |
| Sedentary postmenopausal women in an exercise program | 31 | Average 64.6 | 50 mg a day by mouth, 12 weeks | Body composition, performance, heart risk markers | Exercise helped; DHEA added nothing, though testosterone doubled[7](https://pepvault.app/guides/dhea-for-women#source-7) |
| Women with adrenal insufficiency (crossover) | 24 | Adults | 50 mg each morning, 4 months | Wellbeing, mood, sexuality | Wellbeing, depression and anxiety scores and sexual interest improved[8](https://pepvault.app/guides/dhea-for-women#source-8) |
| Women with adrenal insufficiency (crossover) | 28 completed of 33 | 20 to 80 | 50 mg a day, 12 weeks | Strength, fitness, body composition, muscle protein | No change[9](https://pepvault.app/guides/dhea-for-women#source-9) |
| Poor responders to IVF | 33 (17 DHEA, 16 control) | 18 to 42 | 75 mg a day before and during IVF | Embryos, pregnancy, live birth | Live birth 23.1% vs 4.0%[10](https://pepvault.app/guides/dhea-for-women#source-10) [11](https://pepvault.app/guides/dhea-for-women#source-11) |
| Painful sex after menopause (the two Intrarosa trials) | 255 and 558 (87 and 376 on Intrarosa) | 40 to 75 and 40 to 80 (averages 58.6 and 59.5) | 6.5 mg vaginal insert nightly, 12 weeks | Pain at sex, vaginal cells, pH | Pain eased more than on placebo in both[12](https://pepvault.app/guides/dhea-for-women#source-12) [14](https://pepvault.app/guides/dhea-for-women#source-14) |

Doses are what each trial gave, told as that, not a dose for anyone. The 33-woman IVF trial was small, and its live-birth difference sat right at the line of chance (P = 0.05)[10](https://pepvault.app/guides/dhea-for-women#source-10).

Read down the found column and a pattern shows. Where women already had normal adrenal glands, oral DHEA raised their hormones without moving how they felt or performed. The effects came where something was missing, in adrenal insufficiency, or where the hormone was put straight on the tissue that needed it.

## Who did the pooled reviews count?

A meta-analysis pools many trials into one estimate (pepvault.app/glossary/meta-analysis). Each group of women has had one, and each counted a different kind of woman.

| Group | Review | Trials and women | Who they were | Bottom line |
| --- | --- | --- | --- | --- |
| Peri- and postmenopausal women | Cochrane, 2015 | 28 trials, 1,273 women | Aged 36 to 80, over 95% postmenopausal; DHEA by mouth in over 80% of trials, 10 to 1,600 mg a day | No gain in quality of life; sexual function slightly better; more acne[15](https://pepvault.app/guides/dhea-for-women#source-15) [16](https://pepvault.app/guides/dhea-for-women#source-16) |
| Postmenopausal women, normal adrenals | Mayo Clinic review, 2014 | 23 trials, 1,188 women | Postmenopausal, adrenal glands working; systemic DHEA, not the vaginal insert | No significant gain in libido, lipids, glucose, weight or bone[17](https://pepvault.app/guides/dhea-for-women#source-17) |
| Women with adrenal insufficiency | Meta-analysis, 2009 | 10 trials | Primary or secondary adrenal insufficiency | Quality of life and depression a little better, "perhaps trivial"[18](https://pepvault.app/guides/dhea-for-women#source-18) |
| Women going through IVF | Cochrane, 2024 | 28 trials of DHEA or testosterone, 3,002 women | Poor responders in all but three trials | DHEA: little to no change in live births[19](https://pepvault.app/guides/dhea-for-women#source-19) |

The effect sizes, odds ratios and the trials in men are in DHEA benefits: what the studies show (pepvault.app/guides/dhea-what-studies-show). What this table adds is the spread: the menopause reviews are almost all women past menopause, and the IVF review is almost all women whose ovaries respond poorly.

## With this guide

### DHEA

- [DHEA: the full reference](https://pepvault.app/peptides/dhea)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The Hormones and blood tests path

- [Raising testosterone: TRT vs enclomiphene vs hCG vs kisspeptin](https://pepvault.app/guides/raising-testosterone-trt-vs-others)
- [Enclomiphene vs clomiphene vs TRT: what the trials measured](https://pepvault.app/guides/enclomiphene-clomiphene-trt)
- [hCG vs hMG vs enclomiphene: what each one is and does](https://pepvault.app/guides/hcg-vs-hmg-vs-enclomiphene)
- [When to move up or stay on a hCG dose](https://pepvault.app/guides/hcg-dose-when-to-move-up)
- [ApoB and Lp(a) blood tests: ranges, what they mean and what lowers them](https://pepvault.app/guides/apob-and-lpa-blood-tests)
- [Biological age tests: what an epigenetic clock measures](https://pepvault.app/guides/biological-age-tests)
- [Do NAD+ blood tests mean anything?](https://pepvault.app/guides/nad-blood-tests)
- [Testosterone levels by age: what the blood test numbers mean](https://pepvault.app/guides/testosterone-levels-by-age)
- [Tongkat ali and testosterone: what the trials measured](https://pepvault.app/guides/tongkat-ali-and-testosterone)
- [DHEA benefits: what the studies show](https://pepvault.app/guides/dhea-what-studies-show)
- [Menopause and perimenopause: hormone therapy, what the trials show, and where GLP-1s fit](https://pepvault.app/guides/menopause-perimenopause-and-hrt)
- [Testosterone in women: what the studies included](https://pepvault.app/guides/testosterone-in-women)
- [Intermittent fasting in women: what the studies included](https://pepvault.app/guides/intermittent-fasting-in-women)
- [Ferritin levels: what low and high ferritin mean](https://pepvault.app/guides/ferritin-low-and-high)
- [Insulin resistance tests: HOMA-IR, fasting insulin and the rest compared](https://pepvault.app/guides/insulin-resistance-tests)
- [HbA1c: what the number means](https://pepvault.app/guides/what-hba1c-means)
- [CGM without diabetes: what's normal, and is it worth it?](https://pepvault.app/guides/cgm-without-diabetes)
- [Cortisol belly: what it is and what it isn't](https://pepvault.app/guides/cortisol-belly)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Crossover trial](https://pepvault.app/glossary/crossover-trial)

## Does DHEA help libido in women?

By mouth, mostly not; as a vaginal insert, a small gain. When the Cochrane reviewers split the sexual-function trials by route, five oral trials in 340 women gave a standardized mean difference of 0.11, which was not significant, while one intravaginal trial in 218 women gave 0.42[15](https://pepvault.app/guides/dhea-for-women#source-15). The reviewers’ test did not find the two routes significantly different (P = 0.18), so the split is a lead, not a settled result. That measure puts different questionnaires on one scale: 0.2 is small and 0.5 moderate.

The single trials agree. In 93 postmenopausal women recruited for low desire, 50 mg a day did no better than placebo[5](https://pepvault.app/guides/dhea-for-women#source-5). The exceptions were women over 70 in the DHEAge study and women with adrenal insufficiency, whose own levels are lowest[4](https://pepvault.app/guides/dhea-for-women#source-4) [8](https://pepvault.app/guides/dhea-for-women#source-8). For the wider picture of low desire and its approved treatments, see pepvault.app/conditions/sexual-dysfunction and pepvault.app/peptides/for/libido.

**Commonly reported:** little felt day to day on oral DHEA, oilier skin and breakouts within weeks, and for some women more facial or body hair; on the vaginal insert, less dryness and some discharge as it melts.

## Who did the DHEA studies leave out?

Knowing who was missing matters as much as who was in. Across the trials above:

- **Women on estrogen.** The Mayo trial excluded estrogen replacement, and the low-libido trial enrolled women not using it[3](https://pepvault.app/guides/dhea-for-women#source-3) [5](https://pepvault.app/guides/dhea-for-women#source-5). How DHEA adds to hormone therapy was barely tested; the Cochrane review found too little data to compare the two[15](https://pepvault.app/guides/dhea-for-women#source-15).
- **Women with a history of breast cancer.** Intrarosa was not studied in them, and its label flags this because estrogen is one of the hormones DHEA becomes[12](https://pepvault.app/guides/dhea-for-women#source-12).
- **Pregnant and breastfeeding women.** Intrarosa is for use after menopause only, and its label has no data in pregnancy[12](https://pepvault.app/guides/dhea-for-women#source-12).
- **Women in their 20s and 30s outside IVF.** Apart from the IVF trials (18 to 42) and the adrenal trials, the women were postmenopausal: more than 95% in the Cochrane review[11](https://pepvault.app/guides/dhea-for-women#source-11) [16](https://pepvault.app/guides/dhea-for-women#source-16).
- **Women who are not White.** In the four placebo-controlled Intrarosa trials, 91% of women were White and 7% Black; the Mayo exercise trial enrolled only Caucasian women[7](https://pepvault.app/guides/dhea-for-women#source-7) [12](https://pepvault.app/guides/dhea-for-women#source-12).

## What does DHEA do to a woman's hormones and skin?

In women, oral DHEA is a testosterone source. In the exercise trial, 50 mg a day raised DHEA-S, the form a lab measures, by 650% and total testosterone by 100%[7](https://pepvault.app/guides/dhea-for-women#source-7). In adrenal insufficiency, it brought testosterone back into the normal range and lowered HDL cholesterol, the protective kind[8](https://pepvault.app/guides/dhea-for-women#source-8). That testosterone is why acne and unwanted hair are its side effects in women, nearly four times as likely as on placebo in the pooled trials[15](https://pepvault.app/guides/dhea-for-women#source-15).

The vaginal insert stays local by design, and its trials record a different side effect: discharge as the insert melts, in 5.7% of women against 3.7% on placebo over 12 weeks[12](https://pepvault.app/guides/dhea-for-women#source-12). The Panjari trial, a year of 50 mg by mouth, found no change in lipids, insulin resistance or the womb lining[6](https://pepvault.app/guides/dhea-for-women#source-6), and the two-year Mayo trial reported no major adverse effects[1](https://pepvault.app/guides/dhea-for-women#source-1).

<!--promo-->

PepVault's side-effect log takes acne, hair growth or any symptom you name, dated and rated, so a pattern after starting DHEA is on record rather than remembered. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-dhea-for-women-inline&mt=8)

<!--/promo-->

## Who decides whether DHEA fits a woman?

Her prescriber. The vaginal insert is a prescription drug for pain at sex after menopause[13](https://pepvault.app/guides/dhea-for-women#source-13). Oral DHEA is sold in the US as a supplement, which the FDA does not approve before sale. In its 2014 guideline, the Endocrine Society, with four other societies, recommended against routine DHEA in women with normal adrenal glands or with adrenal insufficiency, citing limited data on effectiveness and safety[20](https://pepvault.app/guides/dhea-for-women#source-20).

A DHEA-S blood test shows whether a woman's level is low to begin with, which is who most of the trials enrolled. The library page, pepvault.app/peptides/dhea, has its timeline, side effects and legal status.

<!--promo-->

PepVault's bloodwork section tracks DHEA-S, total and free testosterone, SHBG and estradiol over time, so each new result sits beside the last one and the day DHEA started. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-dhea-for-women-inline&mt=8)

<!--/promo-->

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Nair KS et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006. [PubMed 17050889](https://pubmed.ncbi.nlm.nih.gov/17050889/)
2. Srinivasan M et al. Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men. J Clin Endocrinol Metab. 2010. [PubMed 20139233](https://pubmed.ncbi.nlm.nih.gov/20139233/)
3. ClinicalTrials.gov. DHEA and Testosterone Replacement in Elderly (NCT00254371), Mayo Clinic. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00254371)
4. Baulieu EE et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A. 2000. [PubMed 10760294](https://pubmed.ncbi.nlm.nih.gov/10760294/)
5. Panjari M et al. A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido. J Sex Med. 2009. [PubMed 19619146](https://pubmed.ncbi.nlm.nih.gov/19619146/)
6. Panjari M et al. The safety of 52 weeks of oral DHEA therapy for postmenopausal women. Maturitas. 2009. [PubMed 19410392](https://pubmed.ncbi.nlm.nih.gov/19410392/)
7. Igwebuike A et al. Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women. J Clin Endocrinol Metab. 2008. [PubMed 18029465](https://pubmed.ncbi.nlm.nih.gov/18029465/)
8. Arlt W et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 1999. [PubMed 10502590](https://pubmed.ncbi.nlm.nih.gov/10502590/)
9. Dhatariya KK et al. Dehydroepiandrosterone replacement therapy in hypoadrenal women: protein anabolism and skeletal muscle function. Mayo Clin Proc. 2008. [PubMed 18990320](https://pubmed.ncbi.nlm.nih.gov/18990320/)
10. Wiser A et al. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod. 2010. [PubMed 20729538](https://pubmed.ncbi.nlm.nih.gov/20729538/)
11. ClinicalTrials.gov. Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment (NCT01145144), Meir Medical Center. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01145144)
12. Intrarosa (prasterone) vaginal insert, prescribing information. DailyMed, version 9, published August 3, 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ada639d4-bac0-2ad0-e053-2a95a90afce7)
13. Drugs@FDA. Intrarosa, NDA 208470: original approval November 16, 2016. [accessdata.fda.gov](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208470)
14. Labrie F et al. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause. 2016. [PubMed 26731686](https://pubmed.ncbi.nlm.nih.gov/26731686/)
15. Scheffers CS et al. Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Cochrane Database Syst Rev. 2015. [PubMed 25879093](https://pubmed.ncbi.nlm.nih.gov/25879093/)
16. Cochrane. Plain language summary: Dehydroepiandrosterone for women in the peri- or postmenopausal phase (CD011066). [cochrane.org](https://www.cochrane.org/evidence/CD011066_dehydroepiandrosterone-women-peri-or-postmenopausal-phase)
17. Elraiyah T et al. The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014. [PubMed 25279571](https://pubmed.ncbi.nlm.nih.gov/25279571/)
18. Alkatib AA et al. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. J Clin Endocrinol Metab. 2009. [PubMed 19773400](https://pubmed.ncbi.nlm.nih.gov/19773400/)
19. Naik S et al. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction. Cochrane Database Syst Rev. 2024. [PubMed 38837771](https://pubmed.ncbi.nlm.nih.gov/38837771/)
20. Wierman ME et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014. [PubMed 25279570](https://pubmed.ncbi.nlm.nih.gov/25279570/)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · Hormones and blood tests

Guide · Hormones and blood tests

### [Testosterone in women: what the studies included](https://pepvault.app/guides/testosterone-in-women)

Who the testosterone trials in women enrolled: menopause type, ages, estrogen use and dose, what each found, and where it is approved. Every trial in one table.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [DHEA Studied range: 100–150 mg](https://pepvault.app/peptides/dhea)

## Related guides

- Guide · Hormones and blood tests

  ### [DHEA benefits: what the studies show](https://pepvault.app/guides/dhea-what-studies-show)

  What DHEA does in human trials, as of November 2026: aging, bone, mood, IVF, the approved vaginal insert, hormone levels, side effects and its legal status.

  Read the guide
- Guide · GLP-1s

  ### [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)

  GLP-1s in menopause: tirzepatide weight loss by menopause stage, semaglutide with hormone therapy, the pill, bone and fractures, and the hot-flash trials.

  Read the guide
- Guide · Hormones and blood tests

  ### [Raising testosterone: TRT vs enclomiphene vs hCG vs kisspeptin](https://pepvault.app/guides/raising-testosterone-trt-vs-others)

  TRT, enclomiphene, hCG and kisspeptin compared: what each does to LH, testosterone and sperm, what the trials measured, and which are approved.

  Read the guide
- Guide · The science

  ### [How to read a peptide study](https://pepvault.app/guides/how-to-read-a-peptide-study)

  How to read a peptide study in ten minutes: the species, how many people, the placebo group, the registered outcome, and what "significant" really means.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### DHEA

- [DHEA: the full reference](https://pepvault.app/peptides/dhea)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The Hormones and blood tests path

- [Raising testosterone: TRT vs enclomiphene vs hCG vs kisspeptin](https://pepvault.app/guides/raising-testosterone-trt-vs-others)
- [Enclomiphene vs clomiphene vs TRT: what the trials measured](https://pepvault.app/guides/enclomiphene-clomiphene-trt)
- [hCG vs hMG vs enclomiphene: what each one is and does](https://pepvault.app/guides/hcg-vs-hmg-vs-enclomiphene)
- [When to move up or stay on a hCG dose](https://pepvault.app/guides/hcg-dose-when-to-move-up)
- [ApoB and Lp(a) blood tests: ranges, what they mean and what lowers them](https://pepvault.app/guides/apob-and-lpa-blood-tests)
- [Biological age tests: what an epigenetic clock measures](https://pepvault.app/guides/biological-age-tests)
- [Do NAD+ blood tests mean anything?](https://pepvault.app/guides/nad-blood-tests)
- [Testosterone levels by age: what the blood test numbers mean](https://pepvault.app/guides/testosterone-levels-by-age)
- [Tongkat ali and testosterone: what the trials measured](https://pepvault.app/guides/tongkat-ali-and-testosterone)
- [DHEA benefits: what the studies show](https://pepvault.app/guides/dhea-what-studies-show)
- [Menopause and perimenopause: hormone therapy, what the trials show, and where GLP-1s fit](https://pepvault.app/guides/menopause-perimenopause-and-hrt)
- [Testosterone in women: what the studies included](https://pepvault.app/guides/testosterone-in-women)
- [Intermittent fasting in women: what the studies included](https://pepvault.app/guides/intermittent-fasting-in-women)
- [Ferritin levels: what low and high ferritin mean](https://pepvault.app/guides/ferritin-low-and-high)
- [Insulin resistance tests: HOMA-IR, fasting insulin and the rest compared](https://pepvault.app/guides/insulin-resistance-tests)
- [HbA1c: what the number means](https://pepvault.app/guides/what-hba1c-means)
- [CGM without diabetes: what's normal, and is it worth it?](https://pepvault.app/guides/cgm-without-diabetes)
- [Cortisol belly: what it is and what it isn't](https://pepvault.app/guides/cortisol-belly)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Crossover trial](https://pepvault.app/glossary/crossover-trial)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
